SOURCE: avVaa World Health Care Products, Inc.
RICHMOND, VA--(Marketwire - Jun 8, 2012) - avVaa World Health Care Products, Inc. ("avVaa" or "the Company") (PINKSHEETS: AVVH) signs private label agreement with Petonic Pet Supply, Inc. for its Dermalustre pet line products.
avVaa World Health Care Products, Inc. signed a private label agreement with Petonic Pet Supply, Inc. (www.petonicpets.com) to distribute avVaa's Dermalustre animal line under the company's own private label. Petonic Pet Supply, Inc. has a distribution agreement with Eyedot Services, Inc. in British Columbia, Canada to distribute its private label pet products to 17 stores throughout British Columbia. Petonic Pet Supply, Inc. signed a distribution agreement in May 2012 with HJG Distribution in the Maritimes and South Quebec, Canada which operates a distribution warehouse with 24 retail stores in their chain.
About avVaa World Health Care Products, Inc.
avVaa is a global biotechnology company that specializes in effective, natural, therapeutic skin care products that improve quality of life and wellbeing for consumers. avVaa's patented European skin care formulas are scientifically registered and NHP‐compliant. The formulas were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin® line of skin care products through mass food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.
Safe Harbor: This news release contains statements which may constitute "forward‐looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of avVaa World Health Care Products, and members of its management, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward‐looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward‐looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward‐statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before‐mentioned transactions. The Company undertakes no obligation to update or revise forward‐looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.